| | | | | | | | | | |
|
| |
|
| Dockets Entered
On October 25, 2006
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
|
|
| 2002P-0122
|
| Request Rulemaking on Functional Foods & Establish Adv. Com.
|
|
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
|
|
| 2004D-0333
|
| Emergency Use Authorization of Medical Products
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
|
|
|
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
|
|
|
|
| 2006D-0353
|
| Guidance for Industry and FDA Staff: Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems
|
|
|
|
|
| 2006D-0400
|
| Global Harmonization Task Force, Study Groups 1, 2, 4, and 5; New Proposed and Final Documents; Availability
|
|
|
|
|
| 2006F-0409
|
| Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767)
|
|
|
|
|
| 2006N-0021
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Request for Samples and Protocols
|
|
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
|
|
| 2006P-0085
|
| To Exempt the Class II device Cranial Orthoses from Premarket Notification Requirements
|
|
|
|
|
| 2006P-0390
|
| Order the Church of Scientology to clearly disclose the potential health hazards inherent in the use of the E-meter and Scientology's practice of "auditing"
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2006V-0429
|
| Projector for a Laser Light Show
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
|
|
| EC 9
|
| Mrs. Georgia Washington
|
| Vol #:
|
| 4
|
|
|
|
|
| 2002P-0122
|
| Request Rulemaking on Functional Foods & Establish Adv. Com.
|
|
|
|
|
| BKG 1
|
| Background Information
|
| Vol #:
|
| 2
|
|
|
|
|
| NHC 1
|
| FDA
|
| Vol #:
|
| 2
|
|
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
|
|
| EC 33
|
| Mr. david lowe
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 34
|
| Mr. david lowe
|
| Vol #:
|
| 5
|
|
| |
|
| 2004D-0333
|
| Emergency Use Authorization of Medical Products
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS 1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| EMC 4023
|
| R. Hines
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4024
|
| G. O'Dell
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4025
|
| P. Hickman
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4026
|
| K. Perino
|
| Vol #:
|
| 195
|
|
| | | | | | | | |
|
| |
|
| EMC 4027
|
| S. Terry
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4028
|
| L. Slaughter
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4029
|
| J. Muessig
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4030
|
| E. Kost
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4031
|
| J. Daily
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4032
|
| M. Brantley
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4033
|
| J. Bradley
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4034
|
| L. Auclair
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4035
|
| A. Jacobi
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4036
|
| H. Barnett
|
| Vol #:
|
| 195
|
|
|
|
|
| EMC 4037
|
| L. Ward
|
| Vol #:
|
| 195
|
|
| |
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
|
|
|
|
| EC 42
|
| Ms. Nancy King
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 43
|
| Council on Governmental Relations
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 44
|
| Dr. Tom Aufderheide
|
| Vol #:
|
| 2
|
|
|
|
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
|
|
|
|
| EC 6
|
| Dr. Jon Rosenblatt
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006D-0353
|
| Guidance for Industry and FDA Staff: Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems
|
|
|
|
|
| GDL 1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006D-0400
|
| Global Harmonization Task Force, Study Groups 1, 2, 4, and 5; New Proposed and Final Documents; Availability
|
|
|
|
|
| GDL 1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006F-0409
|
| Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767)
|
|
|
|
|
| EA 1
|
| Background Information
|
| Vol #:
|
| 1
|
|
|
|
|
| NFL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0021
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Request for Samples and Protocols
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS 1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
|
|
| EC 29
|
| BioPro
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
